InVasc Therapeutics Company
InVasc Therapeutics develops drug-based platforms for diabetes, atherosclerosis, hypertension, and cardiovascular diseases.
Technology:
Cancer
Industry:
PharmTech
Headquarters:
Tucker, Georgia, United States
Founded Date:
2006
Employees Number:
1-10
Funding Status:
Early Stage Venture
Estimated Revenue:
Less than $1M
Register and Claim Ownership